BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33759519)

  • 1. Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazines.
    Priebbenow DL; Mathiew M; Shi DH; Harjani JR; Beveridge JG; Chavchich M; Edstein MD; Duffy S; Avery VM; Jacobs RT; Brand S; Shackleford DM; Wang W; Zhong L; Lee G; Tay E; Barker H; Crighton E; White KL; Charman SA; De Paoli A; Creek DJ; Baell JB
    J Med Chem; 2021 Apr; 64(7):4150-4162. PubMed ID: 33759519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity.
    Xue L; Shi DH; Harjani JR; Huang F; Beveridge JG; Dingjan T; Ban K; Diab S; Duffy S; Lucantoni L; Fletcher S; Chiu FCK; Blundell S; Ellis K; Ralph SA; Wirjanata G; Teguh S; Noviyanti R; Chavchich M; Creek D; Price RN; Marfurt J; Charman SA; Cuellar ME; Strasser JM; Dahlin JL; Walters MA; Edstein MD; Avery VM; Baell JB
    J Med Chem; 2019 Mar; 62(5):2485-2498. PubMed ID: 30715882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials.
    Norcross NR; Baragaña B; Wilson C; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Porzelle A; Grimaldi R; Wittlin S; Duffy S; Avery VM; Meister S; Sanz L; Jiménez-Díaz B; Angulo-Barturen I; Ferrer S; Martínez MS; Gamo FJ; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH
    J Med Chem; 2016 Jul; 59(13):6101-20. PubMed ID: 27314305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarials. 3. 1,2,4-Triazines.
    March LC; Bajwa GS; Lee J; Wasti K; Joullíe MM
    J Med Chem; 1976 Jun; 19(6):845-8. PubMed ID: 781244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids.
    Rodrigues CA; Frade RF; Albuquerque IS; Perry MJ; Gut J; Machado M; Rosenthal PJ; Prudêncio M; Afonso CA; Moreira R
    ChemMedChem; 2015 May; 10(5):883-90. PubMed ID: 25784585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.
    Kumar A; Srivastava K; Kumar SR; Siddiqi MI; Puri SK; Sexana JK; Chauhan PM
    Eur J Med Chem; 2011 Feb; 46(2):676-90. PubMed ID: 21194812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
    Zhang YK; Plattner JJ; Easom EE; Jacobs RT; Guo D; Freund YR; Berry P; Ciaravino V; Erve JCL; Rosenthal PJ; Campo B; Gamo FJ; Sanz LM; Cao J
    J Med Chem; 2017 Jul; 60(13):5889-5908. PubMed ID: 28635296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administration.
    Parkinson CJ; Birrell GW; Chavchich M; Mackenzie D; Haynes RK; de Kock C; Richardson DR; Edstein MD
    J Antimicrob Chemother; 2019 Oct; 74(10):2965-2973. PubMed ID: 31325302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.
    Le Manach C; Paquet T; Brunschwig C; Njoroge M; Han Z; Gonzàlez Cabrera D; Bashyam S; Dhinakaran R; Taylor D; Reader J; Botha M; Churchyard A; Lauterbach S; Coetzer TL; Birkholtz LM; Meister S; Winzeler EA; Waterson D; Witty MJ; Wittlin S; Jiménez-Díaz MB; Santos Martínez M; Ferrer S; Angulo-Barturen I; Street LJ; Chibale K
    J Med Chem; 2015 Nov; 58(21):8713-22. PubMed ID: 26502160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial and antiplasmodial activities of norneolignans. Syntheses and SAR.
    Skytte DM; Nielsen SF; Chen M; Zhai L; Olsen CE; Christensen SB
    J Med Chem; 2006 Jan; 49(1):436-40. PubMed ID: 16392829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials.
    McConville M; Fernández J; Angulo-Barturen Í; Bahamontes-Rosa N; Ballell-Pages L; Castañeda P; de Cózar C; Crespo B; Guijarro L; Jiménez-Díaz MB; Martínez-Martínez MS; de Mercado J; Santos-Villarejo Á; Sanz LM; Frigerio M; Washbourn G; Ward SA; Nixon GL; Biagini GA; Berry NG; Blackman MJ; Calderón F; O'Neill PM
    J Med Chem; 2015 Aug; 58(16):6448-55. PubMed ID: 26222445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice.
    Gujjar R; El Mazouni F; White KL; White J; Creason S; Shackleford DM; Deng X; Charman WN; Bathurst I; Burrows J; Floyd DM; Matthews D; Buckner FS; Charman SA; Phillips MA; Rathod PK
    J Med Chem; 2011 Jun; 54(11):3935-49. PubMed ID: 21517059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
    Ramachandran S; Hameed P S; Srivastava A; Shanbhag G; Morayya S; Rautela N; Awasthy D; Kavanagh S; Bharath S; Reddy J; Panduga V; Prabhakar KR; Saralaya R; Nanduri R; Raichurkar A; Menasinakai S; Achar V; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Waterson D; Lee MC; Coburn-Flynn O; Fidock DA; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK
    J Med Chem; 2014 Aug; 57(15):6642-52. PubMed ID: 25007124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and optimisation studies of antimalarial phenotypic hits.
    Mital A; Murugesan D; Kaiser M; Yeates C; Gilbert IH
    Eur J Med Chem; 2015 Oct; 103():530-8. PubMed ID: 26408453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice.
    Gujjar R; Marwaha A; El Mazouni F; White J; White KL; Creason S; Shackleford DM; Baldwin J; Charman WN; Buckner FS; Charman S; Rathod PK; Phillips MA
    J Med Chem; 2009 Apr; 52(7):1864-72. PubMed ID: 19296651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.
    Van Voorhis WC; Rivas KL; Bendale P; Nallan L; Hornéy C; Barrett LK; Bauer KD; Smart BP; Ankala S; Hucke O; Verlinde CL; Chakrabarti D; Strickland C; Yokoyama K; Buckner FS; Hamilton AD; Williams DK; Lombardo LJ; Floyd D; Gelb MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3659-71. PubMed ID: 17606674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle.
    Le Manach C; Nchinda AT; Paquet T; Gonzàlez Cabrera D; Younis Y; Han Z; Bashyam S; Zabiulla M; Taylor D; Lawrence N; White KL; Charman SA; Waterson D; Witty MJ; Wittlin S; Botha ME; Nondaba SH; Reader J; Birkholtz LM; Jiménez-Díaz MB; Martínez MS; Ferrer S; Angulo-Barturen I; Meister S; Antonova-Koch Y; Winzeler EA; Street LJ; Chibale K
    J Med Chem; 2016 Nov; 59(21):9890-9905. PubMed ID: 27748596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans.
    Malmquist NA; Sundriyal S; Caron J; Chen P; Witkowski B; Menard D; Suwanarusk R; Renia L; Nosten F; Jiménez-Díaz MB; Angulo-Barturen I; Santos Martínez M; Ferrer S; Sanz LM; Gamo FJ; Wittlin S; Duffy S; Avery VM; Ruecker A; Delves MJ; Sinden RE; Fuchter MJ; Scherf A
    Antimicrob Agents Chemother; 2015 Feb; 59(2):950-9. PubMed ID: 25421480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
    Vijayaraghavan S; Mahajan S
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted Aminoacetamides as Novel Leads for Malaria Treatment.
    Norcross NR; Wilson C; Baragaña B; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Fletcher D; Sinden R; Delves M; Ruecker A; Duffy S; Meister S; Antonova-Koch Y; Crespo B; de Cózar C; Sanz LM; Gamo FJ; Avery VM; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis PA; Read KD; Gilbert IH
    ChemMedChem; 2019 Jul; 14(14):1329-1335. PubMed ID: 31188540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.